- Home
- BRTX vs PIII Comparison
BRTX vs PIII Comparison
Compare BRTX & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRTX | PIII |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 10.8M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRTX | PIII |
|---|---|---|
| Price | $0.22 | $2.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.25 |
| AVG Volume (30 Days) | ★ 5.8M | 25.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,000.00 | N/A |
| Revenue This Year | $24.64 | N/A |
| Revenue Next Year | $287.76 | $14.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $0.15 |
| 52 Week High | $2.10 | $11.30 |
Technical Indicators
Market Signals| Indicator | BRTX | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 19.51 | 49.07 |
| Support Level | $0.19 | $1.52 |
| Resistance Level | $0.29 | $2.85 |
| Average True Range (ATR) | 0.03 | 0.20 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 24.98 | 48.72 |
Price Performance
Historical ComparisonAbout BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.